Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gemcabene calcium , a first-in-class lipid-lowering agent, lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C) andexerting anti-inflammatory activity, lowers pro-inflammatory acute-phase protein, C-reactive protein (CRP).
In vitro | Gemcabene calcium (PD-72953 calcium) effectively reduces hepatic mRNA levels associated with inflammation (TNF-α, MCP-1, MIP-1β, CCR5, CCR2, NF-κB), fibrosis (TIMP-1, MMP-2), and processes related to fat production and regulation (ApoC-III, ACC1, ADH-4, Sulf-2). |
別名 | PD-72953 calcium |
分子量 | 344.505 |
分子式 | C16H32CaO5 |
CAS No. | 209789-08-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL (29.37 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemcabene calcium 209789-08-2 Others PD-72953 calcium Inhibitor inhibitor inhibit